Sponsor

Imcyse SA

Clinical research sponsor

Published trials6
Recruiting shown1
Roles2
SourceClinicalTrials.gov

Clinical trials

6 shown
IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS StudyNCT05417269 · lead sponsor · 2022-04-12
UNKNOWN
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)NCT04524949 · lead sponsor · 2020-12-29
TERMINATED
IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or PlaceboNCT04190693 · lead sponsor · 2019-02-14
COMPLETED
Study of IMCY-0098 in Patients With Recent Onset Type 1 DiabetesNCT03272269 · lead sponsor · 2017-08-23
COMPLETED
A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple SclerosisNCT02427776 · lead sponsor · 2015-01-01
TERMINATED
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.NCT06280755 · collaborator · 2024-03-01
RECRUITING

Sponsor roles

lead sponsor5
collaborator1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.